SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-19-016858
Filing Date
2019-03-05
Accepted
2019-03-05 17:55:55
Documents
2
Period of Report
2019-03-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1539
2 POA DOCUMENT poa.txt EX-24.3_839890 1608
  Complete submission text file 0001209191-19-016858.txt   4849
Mailing Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628
Business Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628 609-359-3020
ANTARES PHARMA, INC. (Issuer) CIK: 0001016169 (see all company filings)

IRS No.: 411350192 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3841 Surgical & Medical Instruments & Apparatus

Mailing Address C/O JAZZ PHARMACEUTICALS PLC 5TH FL, WATERLOO EXCHANGE, WATERLOO RD DUBLIN L2 4 L2
Business Address
Smith Karen L. (Reporting) CIK: 0001639637 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-32302 | Film No.: 19659998